FIZZ2/RELM-β induction and role in pulmonary fibrosis

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 450-461

  Liu, Tianju ^a   Baek, Hyun Ah ^b   Yu, Hongfeng ^a   Lee, Ho Jin ^b   Park, Byung Hyun ^b   Ullenbruch, Matthew ^a   Liu, Jianhua ^a   Nakashima, Taku ^a   Choi, Yoon Young ^a   Wu, Gary D ^c   Chung, Myoung Ja ^b   Phan, Sem H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Chonbuk National University   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN TYPE 1; CYTOKINE; FOUND IN INFLAMMATORY ZONE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOFIBROBLASTS; PULMONARY FIBROSIS; RATS; RATS, INBRED F344; TH2 CELLS;

EID: 79960426826     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000964     Document Type: Article

References (59)

1. Gross, T. J., and G. W. Hunninghake. 2001. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345: 517-525.
2. Mason, R. J., M. I. Schwarz, G. W. Hunninghake, and R. A. Musson. 1999. NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am. J. Respir. Crit. Care Med. 160: 1771-1777.
3. Elias, J. A., Z. Zhu, G. Chupp, and R. J. Homer. 1999. Airway remodeling in asthma. J. Clin. Invest. 104: 1001-1006.
4. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524.
5. Evans, J. N., J. Kelley, R. B. Low, and K. B. Adler. 1982. Increased contractility of isolated lung parenchyma in an animal model of pulmonary fibrosis induced by bleomycin. Am. Rev. Respir. Dis. 125: 89-94.
6. Phan, S. H., J. Varani, and D. Smith. 1985. Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 76: 241-247.
7. Zhang, H. Y., M. Gharaee-Kermani, K. Zhang, S. Karmiol, and S. H. Phan. 1996. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 148: 527-537.
8. Jakubzick, C., E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam. 2003. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J. Immunol. 171: 2684-2693.
9. Selman, M., T. E. King, and A. Pardo; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134: 136-151.
10. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125.
11. Liu, T., S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, and S. H. Phan. 2004. FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 164: 1315-1326.
12. Liu, T., B. Hu, Y. Y. Choi, M. Chung, M. Ullenbruch, H. Yu, J. B. Lowe, and S. H. Phan. 2009. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation. Am. J. Pathol. 174: 1745-1755.
13. Liu, T., H. Jin, M. Ullenbruch, B. Hu, N. Hashimoto, B. Moore, A. McKenzie, N. W. Lukacs, and S. H. Phan. 2004. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J. Immunol. 173: 3425-3431.
14. Chung, M. J., T. Liu, M. Ullenbruch, and S. H. Phan. 2007. Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts. J. Pathol. 212: 180-187.
15. Steppan, C. M., E. J. Brown, C. M. Wright, S. Bhat, R. R. Banerjee, C. Y. Dai, G. H. Enders, D. G. Silberg, X. Wen, G. D. Wu, and M. A. Lazar. 2001. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA 98: 502-506.
16. Gerstmayer, B., D. Küsters, S. Gebel, T. Müller, E. Van Miert, K. Hofmann, and A. Bosio. 2003. Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern. Genomics 81: 588-595. (Pubitemid 36627503)
17. Holcomb, I. N., R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19: 4046-4055. (Pubitemid 30608543)
18. Mishra, A., M. Wang, J. Schlotman, N. M. Nikolaidis, C. W. DeBrosse, M. L. Karow, and M. E. Rothenberg. 2007. Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L305-L313.
19. Shojima, N., T. Ogihara, K. Inukai, M. Fujishiro, H. Sakoda, A. Kushiyama, H. Katagiri, M. Anai, H. Ono, Y. Fukushima, et al. 2005. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia 48: 984-992. (Pubitemid 40767993)
20. Kushiyama, A., N. Shojima, T. Ogihara, K. Inukai, H. Sakoda, M. Fujishiro, Y. Fukushima, M. Anai, H. Ono, N. Horike, et al. 2005. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J. Biol. Chem. 280: 42016-42025.
21. Artis, D., M. L. Wang, S. A. Keilbaugh, W. He, M. Brenes, G. P. Swain, P. A. Knight, D. D. Donaldson, M. A. Lazar, H. R. Miller, et al. 2004. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. USA 101: 13596-13600.
22. Hogan, S. P., L. Seidu, C. Blanchard, K. Groschwitz, A. Mishra, M. L. Karow, R. Ahrens, D. Artis, A. J. Murphy, D. M. Valenzuela, et al. 2006. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118: 257-268.
23. Renigunta, A., C. Hild, F. Rose, W. Klepetko, F. Grimminger, W. Seeger, and J. Hänze. 2006. Human RELMbeta is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett. 580: 900-903. (Pubitemid 43152312)
24. Angelini, D. J., Q. Su, K. Yamaji-Kegan, C. Fan, X. Teng, P. M. Hassoun, S. C. Yang, H. C. Champion, R. M. Tuder, and R. A. Johns. 2009. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 41: 553-561.
25. Homer, R. J. 2007. Airway remodeling and RELM-beta. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L303-L304.
26. Brasch-Andersen, C., A. Haagerup, A. D. Børglum, J. Vestbo, and T. A. Kruse. 2006. Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J. Med. Genet. 43: e10.
27. McVay, L. D., S. A. Keilbaugh, T. M. Wong, S. Kierstein, M. E. Shin, M. Lehrke, M. I. Lefterova, D. E. Shifflett, S. L. Barnes, F. Cominelli, et al. 2006. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116: 2914-2923.
28. McKenzie, G. J., P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N. McKenzie. 1999. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189: 1565-1572.
29. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
30. Hashimoto, N., H. Jin, T. Liu, S. W. Chensue, and S. H. Phan. 2004. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113: 243-252.
31. Dobbs, L. G. 1990. Isolation and culture of alveolar type II cells. Am. J. Physiol. 258: L134-L147.
32. Edwards, C. A., and W. D. O'Brien Jr. 1980. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta 104: 161-167.
33. Irizarry, R. A., B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
34. Ritchie, M. E., D. Diyagama, J. Neilson, R. van Laar, A. Dobrovic, A. Holloway, and G. K. Smyth. 2006. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7: 261.
35. Wilson, M. S., S. K. Madala, T. R. Ramalingam, B. R. Gochuico, I. O. Rosas, A. W. Cheever, and T. A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207: 535-552.
36. Segel, M. J., G. Izbicki, P. Y. Cohen, R. Or, T. G. Christensen, S. B. Wallach-Dayan, and R. Breuer. 2003. Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1255-L1262.
37. Gao, J., B. P. De, and A. K. Banerjee. 1999. Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway. J. Virol. 73: 1411-1418.
38. Hwang, S. Y., J. Y. Kim, K. W. Kim, M. K. Park, Y. Moon, W. U. Kim, and H. Y. Kim. 2004. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6: R120-R128.
39. Strieter, R. M., E. C. Keeley, M. A. Hughes, M. D. Burdick, and B. Mehrad. 2009. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 86: 1111-1118.
40. Moeller, A., S. E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P. J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, et al. 2009. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179: 588-594.
41. Liu, T., M. J. Chung, M. Ullenbruch, H. Yu, H. Jin, B. Hu, Y. Y. Choi, F. Ishikawa, and S. H. Phan. 2007. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J. Clin. Invest. 117: 3800-3809.
42. Munitz, A., A. Waddell, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2008. Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 122: 1200-1207.e1.
43. Gharaee-Kermani, M., M. R. Gyetko, B. Hu, and S. H. Phan. 2007. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. Pharm. Res. 24: 819-841.
44. Gharaee-Kermani, M., and S. H. Phan. 2001. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr. Pharm. Des. 7: 1083-1103.
45. Phan, S. H. 2002. The myofibroblast in pulmonary fibrosis. Chest 122(6, Suppl): 286S-289S.
46. Mattey, D. L., P. T. Dawes, N. B. Nixon, and H. Slater. 1997. Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann. Rheum. Dis. 56: 426-431.
47. Jakubzick, C., E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam. 2003. Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts. Am. J. Pathol. 162: 1475-1486.
48. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (New York, N.Y.) 270: 1326-1331.
49. Sebolt-Leopold, J. S., and R. Herrera. 2004. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4: 937-947.
50. Roymans, D., and H. Slegers. 2001. Phosphatidylinositol 3-kinases in tumor progression. Eur. J. Biochem. 268: 487-498.
51. Connolly, M. K., A. S. Bedrosian, J. Mallen-St Clair, A. P. Mitchell, J. Ibrahim, A. Stroud, H. L. Pachter, D. Bar-Sagi, A. B. Frey, and G. Miller. 2009. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 119: 3213-3225.
52. Bantsimba-Malanda, C., J. Marchal-Sommé, D. Goven, O. Freynet, L. Michel, B. Crestani, and P. Soler. 2010. A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? Am. J. Respir. Crit. Care Med. 182: 385-395.
53. Marchal-Sommé, J., Y. Uzunhan, S. Marchand-Adam, M. Kambouchner, D. Valeyre, B. Crestani, and P. Soler. 2007. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am. J. Respir. Crit. Care Med. 176: 1007-1014.
54. Tsoumakidou, M., K. P. Karagiannis, I. Bouloukaki, S. Zakynthinos, N. Tzanakis, and N. M. Siafakas. 2009. Increased bronchoalveolar lavage fluid CD1c expressing dendritic cells in idiopathic pulmonary fibrosis. Respiration 78: 446-452.
55. Phillips, R. J., M. D. Burdick, K. Hong, M. A. Lutz, L. A. Murray, Y. Y. Xue, J. A. Belperio, M. P. Keane, and R. M. Strieter. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114: 438-446.
56. Ceradini, D. J., A. R. Kulkarni, M. J. Callaghan, O. M. Tepper, N. Bastidas, M. E. Kleinman, J. M. Capla, R. D. Galiano, J. P. Levine, and G. C. Gurtner. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10: 858-864.
57. Xu, J., A. Mora, H. Shim, A. Stecenko, K. L. Brigham, and M. Rojas. 2007. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am. J. Respir. Cell Mol. Biol. 37: 291-299.
58. Song, J. S., C. M. Kang, H. H. Kang, H. K. Yoon, Y. K. Kim, K. H. Kim, H. S. Moon, and S. H. Park. 2010. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp. Mol. Med. 42: 465-472.
59. Yamaji-Kegan, K., Q. Su, D. J. Angelini, H. C. Champion, and R. A. Johns. 2006. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1159-L1168.